. 2018 Jan 20;34(6):1347–1362. doi: 10.3904/kjim.2017.098

Table 3.

Medical costs

No	Author	Year	Medical costs		p value
No	Author	Year	MRSA	MSSA	p value
1	Rubio-Terres [37]	2009	€11,044.59/episode^a	€9839.25/episode^a	-
2	Ben-David [33]	2009	ICU origin: $113,852 (48,961–55,001)^b	ICU origin: $42,137 (32,388–74,781)^b	ICU origin: < 0.001
2	Ben-David [33]	2009	General origin: $53,409 (32,945–84,053)^b	General origin: $35,131 (18,340–50,896)^b	General origin: 0.005
3	Greiner [46]	2006	€24,931^a	€10,573^a	< 0.05
4	Lodise [62]	2005	$21,577 (17,061–27,290)^c	$11,668 (9,550–14,223)^c	0.001
5	Reed [63]	2005	$28,297 ± 23,619^d	$16,066 ± 16,337^d	< 0.0001
6	Cosgrove [76]	2001	$26,424 (14,006–50,484)^b	$19,212 (9,999–36,548)^b	0.008

MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus; ICU, intensive care unit.

Mean.

Median (interquartile range).

Mean (95% confidence interval).

Mean ± SD.